Ignite Creation Date:
2025-12-24 @ 5:58 PM
Ignite Modification Date:
2025-12-27 @ 1:29 PM
Study NCT ID:
NCT06536868
Status:
RECRUITING
Last Update Posted:
2024-08-05
First Post:
2024-07-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC
Sponsor:
Second Hospital of Shanxi Medical University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Extensive-stage Small-cell Lung Cancer | View |
Keywords: